PR92426

SEOUL, South Korea, Oct. 20, 2021 /PRNewswire=KYODO JBN/ --

Korean Ginseng Research Institute, recently published research results on 'the

vaccine adjuvant effect of red ginseng' and 'respiratory damage prevention

effect'. It is said that red ginseng acts as a potential vaccine

adjuvant(https://www.sciencedirect.com/science/article/pii/S1226845320301883)

[1] by enhancing the efficacy of the vaccine.

https://mma.prnewswire.com/media/1662576/Red_Ginseng_image.jpg

The results of the study showed that red ginseng increased the effectiveness of

the vaccine, so that when red ginseng was taken together, the antiviral effect

was enhanced and prevented lung damage caused by various viruses compared to

when the vaccine was administered alone. The study results that ingestion of

red ginseng at the same time as the vaccination at the time the inoculation of

the corona virus vaccine started can increase the vaccine effect is significant

in that it suggests the possibility of speeding up the overcoming of the

COVID-19.

In the paper 'Protective Effect of Korean Red Ginseng Extract on the Infections

by H1N1 and H3N2 Influenza Viruses in Mice' published in 2021 in the 'Journal

of Medicinal Food', an international academic journal, it was confirmed that

the survival rate of mice vaccinated with red ginseng concentrate was higher

than that of mice vaccinated alone. After administering the red ginseng

concentrate to mice for 14 days, the vaccine was inoculated, and after the last

administration of the red ginseng concentrate, the mice got infected with

influenza virus (H1N1, H3N2) and observed. As a result, it was found that when

the red ginseng concentrate was administered, the virus defense effect was

strengthened and the production of viral inflammatory substances in the lungs

was reduced.

In the paper 'Korean Red Ginseng enhances pneumococcal pep27 vaccine efficacy

by inhibiting reactive oxygen species production' published in 'Journal of

Ginseng Research' in 2019, red ginseng concentrate was administered to mice.

After administration of the vaccine (pep27) and infection with pneumococcus, it

was observed that the red ginseng concentrate increased the antibody formation

and survival rate of mice infected with pneumococcus, and reduced the time

required for immunization by enhancing the efficacy of the vaccine.

The Institute said that these research results proved the vaccine adjuvant

effect and respiratory damage prevention effect of red ginseng, and plans to

continue researching on various viruses through clinical trials.

[1]. Scientific reference about COVID-19 vaccine adjuvant effect of Ginseng:

https://www.sciencedirect.com/science/article/pii/S1226845320301883

Source: Korean Ginseng Research Institute

Image Attachments Links:

   Link: http://asianetnews.net/view-attachment?attach-id=404410

   Caption: Red Ginseng